Victory Capital Management
EVH icon

Victory Capital Management’s Evolent Health EVH Stock Holding History

Victory Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.7K Buy
11,752
+24
+0.2% +$92 ﹤0.01% 2372
2026
Q1 		$26.7K Sell
11,728
-127
-1% -$403 ﹤0.01% 2362
2025
Q4 		$47.4K Sell
11,855
-1,306
-10% -$7.26K ﹤0.01% 2334
2025
Q3 		$111K Sell
13,161
-491
-4% -$4.76K ﹤0.01% 2287
2025
Q2 		$154K Sell
13,652
-153
-1% -$1.41K ﹤0.01% 2281
2025
Q1 		$131K Sell
13,805
-28
-0.2% -$283 ﹤0.01% 2279
2024
Q4 		$156K Sell
13,833
-215
-2% -$3.78K ﹤0.01% 2277
2024
Q3 		$397K Sell
14,048
-241
-2% -$6.21K ﹤0.01% 2071
2024
Q2 		$273K Sell
14,289
-414,447
-97% -$10.6M ﹤0.01% 2124
2024
Q1 		$14.1M Sell
428,736
-228,782
-35% -$7.3M 0.01% 939
2023
Q4 		$21.7M Sell
657,518
-127,843
-16% -$3.62M 0.02% 744
2023
Q3 		$21.4M Sell
785,361
-197,089
-20% -$5.48M 0.02% 730
2023
Q2 		$29.8M Sell
982,450
-181,714
-16% -$5.88M 0.03% 608
2023
Q1 		$37.8M Sell
1,164,164
-105,820
-8% -$3.35M 0.04% 539
2022
Q4 		$35.7M Buy
1,269,984
+242,088
+24% +$6.94M 0.04% 577
2022
Q3 		$36.9M Buy
1,027,896
+572,503
+126% +$20.2M 0.04% 573
2022
Q2 		$14M Buy
455,393
+425,953
+1,447% +$12.4M 0.02% 953
2022
Q1 		$810K Buy
29,440
+81
+0.3% +$2.12K ﹤0.01% 1914
2021
Q4 		$812K Sell
29,359
-5,303
-15% -$152K ﹤0.01% 1927
2021
Q3 		$1.07M Buy
34,662
+11,260
+48% +$270K ﹤0.01% 1830
2021
Q2 		$494K Buy
23,402
+11,233
+92% +$225K ﹤0.01% 2213
2021
Q1 		$246K Sell
12,169
-333
-3% -$6.33K ﹤0.01% 2469
2020
Q4 		$200K Buy
12,502
+1,478
+13% +$19.5K ﹤0.01% 2375
2020
Q3 		$137K Sell
11,024
-1,767
-14% -$20.8K ﹤0.01% 2324
2020
Q2 		$91K Sell
12,791
-1,004
-7% -$6.72K ﹤0.01% 2364
2020
Q1 		$75K Sell
13,795
-1,231
-8% -$11K ﹤0.01% 2396
2019
Q4 		$136K Buy
15,026
+3,810
+34% +$31K ﹤0.01% 2430
2019
Q3 		$81K Buy
+11,216
New +$80.5K ﹤0.01% 2502

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Victory Capital Management's EVH Position: Q2 2026 in Review

Victory Capital Management increased its Evolent Health (EVH) stake by 0.2% in Q2 2026, buying an estimated $92 and bringing the position to 11,752 shares worth $63.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2372.

Victory Capital Management first reported a position in EVH in Q3 2019 and has held it in 28 quarters since. The position peaked at $37.8M in Q1 2023. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Victory Capital Management held 11,752 shares of Evolent Health worth $63.7K as of Q2 2026.
  • Victory Capital Management bought 24 Evolent Health shares in Q2 2026, an estimated $92.
  • Evolent Health made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2372 holding.
  • Victory Capital Management first reported a position in Evolent Health in Q3 2019 and has held it in 28 quarters since.
  • Victory Capital Management's Evolent Health position peaked at $37.8M in Q1 2023.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.